法国辩论向美国投资者出售其顶级止痛药多利普兰(Doliprane)一事, France debates the sale of its top painkiller, Doliprane, to US investors, raising national sovereignty concerns.

法国正在讨论向美国投资者出售其顶级销售止痛药Doliprane的建议, France is debating the proposed sale of Doliprane, its top-selling painkiller, to US investors, sparking concerns over national sovereignty. Sanofi正与私人股权公司Clayton、Dubiier & Rice谈判, 以出售其子公司Opella的50%股权。 Sanofi is negotiating with private equity firm Clayton, Dubilier & Rice to sell a 50% stake in its subsidiary Opella. 法国官员要求奥贝拉的总部和决策留在法国,强调职业安全和生产保障。 French officials demand that Opella's headquarters and decision-making remain in France, emphasizing job security and production guarantees. 不遵守规定,政府可以阻止交易或寻求国家参与。 Without compliance, the government may block the deal or seek state involvement.